About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Clinical and Experimental Neuroimmunology
›
top-articles
Clinical and Experimental Neuroimmunology
0.6
(top 50%)
impact factor
594
(top 50%)
papers
2.6K
(top 50%)
citations
23
(top 20%)
h
-index
0.6
(top 50%)
impact factor
871
all documents
2.8K
doc citations
36
(top 20%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Evaluation of aquaporin‐4 antibody assays
Clinical and Experimental Neuroimmunology
2014
106
2
Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease
Clinical and Experimental Neuroimmunology
2012
79
3
T cell migration into the central nervous system during health and disease: Different molecular keys allow access to different central nervous system compartments
Clinical and Experimental Neuroimmunology
2010
78
4
Neuroinflammation in mouse models of Alzheimer's disease
Clinical and Experimental Neuroimmunology
2018
77
5
J
apanese clinical guidelines for myasthenia gravis: Putting into practice
Clinical and Experimental Neuroimmunology
2015
63
6
Neurotoxicity by microglia: Mechanisms and potential therapeutic strategy
Clinical and Experimental Neuroimmunology
2010
62
7
Microglia communication: Parallels between aging and Alzheimer's disease
Clinical and Experimental Neuroimmunology
2016
60
8
Neuron–astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation
Clinical and Experimental Neuroimmunology
2015
44
9
Helicobacter pylori
and gut microbiota in multiple sclerosis versus Alzheimer's disease: 10 pitfalls of microbiome studies
Clinical and Experimental Neuroimmunology
2017
43
10
Neuroinflammation in motor neuron disease
Clinical and Experimental Neuroimmunology
2016
41
11
Neurological safety of fingolimod: An updated review
Clinical and Experimental Neuroimmunology
2017
40
12
Bevacizumab is safe in acute relapses of neuromyelitis optica
Clinical and Experimental Neuroimmunology
2015
39
13
Neuro‐COVID‐19
Clinical and Experimental Neuroimmunology
2022
38
14
What drives disease in multiple sclerosis: Inflammation or neurodegeneration?
Clinical and Experimental Neuroimmunology
2010
36
15
Optic neuritis after COVID‐19 vaccine application
Clinical and Experimental Neuroimmunology
2022
35
16
Reactive astrocytes and perivascular macrophages express
NLRP
3 inflammasome in active demyelinating lesions of multiple sclerosis and necrotic lesions of neuromyelitis optica and cerebral infarction
Clinical and Experimental Neuroimmunology
2013
29
17
Phenotypic heterogeneity of astrocytes in motor neuron disease
Clinical and Experimental Neuroimmunology
2018
29
18
Stable human brain microvascular endothelial cell line retaining its barrier‐specific nature independent of the passage number
Clinical and Experimental Neuroimmunology
2013
26
19
Lymphatic system and gut microbiota affect immunopathology of neuroinflammatory diseases, including multiple sclerosis, neuromyelitis optica and Alzheimer's disease
Clinical and Experimental Neuroimmunology
2017
26
20
Prevalence and characteristics of transverse myelitis and neuromyelitis optica spectrum disorders in the United Arab Emirates: A multicenter, retrospective study
Clinical and Experimental Neuroimmunology
2018
26
21
Chronic inflammatory demyelinating polyneuropathy: Clinical subtypes and their correlation with electrophysiology
Clinical and Experimental Neuroimmunology
2011
25
22
Role of CCR2 in immunobiology and neurobiology
Clinical and Experimental Neuroimmunology
2012
25
23
Role of antiproliferative gene
Tob1
in the immune system
Clinical and Experimental Neuroimmunology
2014
24
24
Clinical features and treatment status of adult myasthenia gravis in
J
apan
Clinical and Experimental Neuroimmunology
2014
24
25
Active form of vitamin D directly protects the blood–brain barrier in multiple sclerosis
Clinical and Experimental Neuroimmunology
2017
24
26
Role of the thymus in autoimmune myasthenia gravis
Clinical and Experimental Neuroimmunology
2016
23
27
Dysregulated T cells in multiple sclerosis
Clinical and Experimental Neuroimmunology
2018
23
28
Roles of glial cells in neuroinflammation and neurodegeneration
Clinical and Experimental Neuroimmunology
2013
22
29
Mind over cytokines: Crosstalk and regulation between the neuroendocrine and immune systems
Clinical and Experimental Neuroimmunology
2012
21
30
Establishment and characterization of spinal cord microvascular endothelial cell lines
Clinical and Experimental Neuroimmunology
2013
20
31
Prevalence, treatments and medical cost of multiple sclerosis in Japan based on analysis of a health insurance claims database
Clinical and Experimental Neuroimmunology
2017
20
32
Anatomy and roles of lymphatics in inflammatory diseases
Clinical and Experimental Neuroimmunology
2017
20
33
Effects of prolonged treatment with memantine in the
MRL
model of central nervous system lupus
Clinical and Experimental Neuroimmunology
2012
19
34
Regulatory T cells in multiple sclerosis
Clinical and Experimental Neuroimmunology
2020
19
35
Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (
C
row–
F
ukase) syndrome: Diagnostic criteria and treatment perspectives
Clinical and Experimental Neuroimmunology
2013
18
36
Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin‐4 channelopathies
Clinical and Experimental Neuroimmunology
2014
18
37
Connexins in health and disease
Clinical and Experimental Neuroimmunology
2018
18
38
Guillain–Barré syndrome after coronavirus disease 2019 vaccine: A temporal association
Clinical and Experimental Neuroimmunology
2022
18
39
Immune response after striatal engraftment of fetal neuronal cells in patients with Huntington’s disease: Consequences for cerebral transplantation programs
Clinical and Experimental Neuroimmunology
2011
17
40
New diagnostic criteria could distinguish common variable immunodeficiency disorder from anticonvulsant‐induced hypogammaglobulinemia
Clinical and Experimental Neuroimmunology
2015
17
41
Bioinformatics approach to identifying molecular biomarkers and networks in multiple sclerosis
Clinical and Experimental Neuroimmunology
2010
15
42
Three immune‐mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditis
Clinical and Experimental Neuroimmunology
2016
15
43
Drug‐induced progressive multifocal leukoencephalopathy in multiple sclerosis: A comprehensive review
Clinical and Experimental Neuroimmunology
2018
15
44
Neuron–microglia interactions in neuroinflammation
Clinical and Experimental Neuroimmunology
2015
14
45
Current treatment status and medical cost for multiple sclerosis based on analysis of a Japanese claims database
Clinical and Experimental Neuroimmunology
2016
14
46
Novel roles of oligodendrocyte precursor cells in the developing and damaged brain
Clinical and Experimental Neuroimmunology
2017
14
47
Pathogenesis of Theiler’s murine encephalomyelitis virus‐induced disease
Clinical and Experimental Neuroimmunology
2010
13
48
Myelin oligodendrocyte glycoprotein immunoglobulin G‐associated disease: An overview
Clinical and Experimental Neuroimmunology
2018
13
49
Gene expression profiles of M1 and M2 microglia characterized by comparative analysis of public datasets
Clinical and Experimental Neuroimmunology
2018
13
50
Pathogenic roles of antiganglioside antibodies in immune‐mediated neuropathies
Clinical and Experimental Neuroimmunology
2013
12
site/software ©
exaly
; All materials licenced under
CC by-SA
.